Clinical Trial

A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 7, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of newly diagnosed or Recurrent Breast Carcinoma in frail or elderly patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-12-31; most recent amendment 2025-02-06.
Status change: Not Yet Recruiting → Recruiting 2024-05-16
Trial Details
NCT Number NCT06202118
Lead Sponsor Alpha Tau Medical LTD.
Conditions Breast Cancer, Recurrent Breast Cancer, Breast Carcinoma
Enrollment 10 participants
Start Date 2024-02-19
Primary Completion 2026-01 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-02-07